Celltrion Pharm, Inc.
Celltrion Pharm, Inc., a leading biopharmaceutical company headquartered in South Korea (KR), has established itself as a key player in the global healthcare industry since its founding in 2002. With a strong focus on the development and manufacturing of biosimilars and innovative therapeutics, Celltrion operates extensively across major markets, including Europe, the United States, and Asia. The company is renowned for its core products, which include monoclonal antibodies and biosimilars that offer cost-effective alternatives to expensive biologics. Celltrion's commitment to quality and innovation has positioned it as a trusted name in the biopharmaceutical sector, achieving significant milestones such as the successful launch of its flagship biosimilar, Remsima. With a robust pipeline and a dedication to advancing healthcare solutions, Celltrion Pharm continues to make strides in improving patient outcomes worldwide.
DitchCarbon Score
How does Celltrion Pharm, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Celltrion Pharm, Inc.'s score of 15 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Celltrion Pharm, Inc.'s reported carbon emissions
Celltrion Pharm, Inc., headquartered in South Korea (KR), currently does not have available data on its carbon emissions, as no specific emissions figures have been reported. Consequently, there are no documented reduction targets or climate commitments outlined by the company at this time. In the context of the pharmaceutical industry, companies are increasingly recognising the importance of addressing climate change and reducing their carbon footprints. While Celltrion Pharm may not have publicly disclosed its emissions data or reduction initiatives, it is essential for organisations in this sector to establish clear climate commitments and set measurable targets to contribute to global sustainability efforts. As the industry evolves, stakeholders are encouraged to monitor Celltrion Pharm's future announcements regarding its climate strategies and emissions management.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Celltrion Pharm, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
